| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |